Acknowledgements This work was supported by the Plans for Major Provincial Science & Technology Projects (202303a07020002 to Z.Z.), the National Key Research and Development Program of China (STI2030-Major Projects 2021ZD0203100 to Z.Z.), the National Natural Science Foundation of China (32025017 to Z.Z., 32121002 to Z.Z., 32400824 to P.C., 32522044 to P.C., U24A20702 to P.C.), the Anhui Provincial Natural Science Foundation (2308085QH264 to P.C.), the CAS Project for Young Scientists in Basic Research (YSBR-013 to Z.Z.), the Fundamental Research Funds for the Central Universities (WK9100250108 and WK9100000068 to P.C.), and the USTC Research Funds of the Double First-Class Initiative (YD9100002501 to Z.Z.)
Theres no revenue share, no equity stake, and no long-term contracts to worry about
Finally, the receptor pool that IGF-I uses for driving hypertrophy may provide another potential avenue for therapeutic strategies
Those under consideration next month include BPC-157, TB-500 and MOTs-C, among others that have grown popular among influencers and some clinicians
